Is Amylyx Pharmaceuticals, Inc. (AMLX) a Buy, Sell, or Hold?
Amylyx Pharmaceuticals, Inc.
NASDAQ:AMLX
$18.2 USD
$0.79 (4.54%)
- Volume
- 2.02M
- Average Volume
- 1.35M
- Market Capitalization
- $1.51B
- P/E Ratio
- -12.30
- Dividend Yield
- 0.00%
- Price Target
- $34.00
- Year High
- $19.15
- Year Low
- $7.48
- Day High
- —
- Day Low
- —
- Payout Ratio
- $0.00
- Current Ratio
- $17.85
Analyst Rating
Sell
2 Rating Score
UPSIDE/DOWNSIDE
-46.5% DOWNSIDE
$34.00 Price Target
UPSIDE/DOWNSIDE HIGH
-54.5% DOWNSIDE
$40.00 Price Target High
UPSIDE/DOWNSIDE LOW
-13.3% DOWNSIDE
$21.00 Price Target Low
INSIDER TRADING
Shares
$- Last Quarter
| Analyst Company | Analyst Name | Price Target | Price When Posted | Date | Upside/Downside |
|---|---|---|---|---|---|
| H.C. Wainwright | Andrew Fein | $34 | $13.32 | 2026-06-08 06:55 AM | 155.3% |
| Mizuho Securities | Graig Suvannavejh | $21 | $16.88 | 2026-04-28 06:41 AM | 24.4% |
| H.C. Wainwright | Andrew Fein | $28 | $14.22 | 2026-02-10 06:10 AM | 96.9% |
| Robert W. Baird | Joel Beatty | $19 | $15.79 | 2025-10-16 07:13 AM | 20.3% |
| Guggenheim | Seamus Fernandez | $25 | $11.85 | 2025-09-15 06:38 AM | 111.0% |
| Guggenheim | Seamus Fernandez | $17 | $6.41 | 2025-06-24 06:13 AM | 165.2% |
| Leerink Partners | Marc Goodman | $10 | $4.65 | 2025-05-06 05:00 PM | 115.1% |